Adverse Effects and Patient Safety
Adverse Effects and Patient Safety Resources | |
| | |
|Australian Adverse Drug | |
|Reactions Bulletin | |
| |This Bulletin is produced six times a year by the Adverse Drug Reactions Advisory Committee. |
| | |
|Canadian Adverse Drug Reaction | |
|Monitoring Program (CADRMP) | |
|Adverse Reaction Database |CADRMP at Health Canada is responsible for the collection and assessment of adverse reaction reports for the |
| |following Canadian marketed health products: pharmaceuticals, biologics (including blood products as well as |
| |therapeutic and diagnostic vaccines), natural health products, and radiopharmaceuticals. |
| | |
|European Agency for the | |
|Evaluation of Medicinal Products| |
|(EMEA) |EMEA is a decentralized body of the European Union with headquarters in London and is responsible for the |
| |scientific evaluation of applications for European marketing authorization for medicinal products. |
| | |
|Health Canada. Advisories, | |
|Warnings and Recalls | |
| |The Department posts safety alerts, public health advisories, press releases and other notices related to |
| |therapeutic health products from industry to health professionals, consumers and other interested parties. |
| | |
|Medicines and Healthcare | |
|Products Regulatory Agency | |
|(MHRA) |The Agency is responsible for ensuring that medicines and medical devices work, and are acceptably safe. |
| | |
|Prescriber Update (NZ) | |
| | |
| |A publication of Medsafe, Prescriber Update presents articles written for health professionals interested in |
| |safer, more effective use of medicines and treatments. |
| | |
|Swiss Medic: Swiss Agency for | |
|Therapeutic Products | |
| |The Agency protects humans and animals by ensuring that only high-quality, safe and effective medicines and |
| |medical devices are placed on the market in Switzerland. |
| | |
|TOXLINE | |
| |Toxicological, pharmacological, biochemical and physiological effects of drugs and other chemicals. |
| | |
|TOXNET | |
| |Databases on toxicology, hazardous chemicals, environmental health, and toxic releases. |
| | |
|U.S. Food and Drug | |
|Administration (FDA) – Center | |
|for Drug Evaluation and Research|The Center for Drug Evaluation and Research (CDER) assures that safe and effective drugs are available to the|
| |American people. |
| | |
|WHO Pharmaceuticals Newsletter | |
| | |
| |This WHO (World Health Organization) Newsletter aims to disseminate information on the safety and efficacy of|
| |pharmaceutical products, based on information received from our network of "drug information officers" and |
| |other sources such as specialized bulletins and journals. |
| | |
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- patient safety in ambulatory setting
- icd 10 adverse effects sequencing
- coding adverse effects icd 10
- adverse event and adverse reaction
- patient safety issues in nursing
- mental health patient safety goals
- ambulatory care patient safety goals
- patient safety in healthcare
- ambulatory patient safety toolkit
- improving patient safety in hospitals
- patient safety ambulatory care
- adverse effects of baking soda